Patents by Inventor Abhilasha Yadav

Abhilasha Yadav has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220151923
    Abstract: The present invention relates to a stable liquid pharmaceutical composition of pemetrexed for parenteral administration. The invention provides composition comprising pemetrexed diacid, an organic amine and cyclodextrin. The composition may further comprise an inert gas. The composition can be ready to use infusion solution of pemetrexed diacid or liquid concentrate formulation to be diluted before administration to the patient. The present invention further relates to a process for manufacturing the compositions as well as use of the compositions of the invention for the treatment of malignant pleural mesothelioma and non-small cell lung cancer.
    Type: Application
    Filed: September 27, 2021
    Publication date: May 19, 2022
    Applicant: FRESENIUS KABI ONCOLOGY LIMITED
    Inventors: Dhiraj KHATTAR, Rajesh KHANNA, Abhilasha YADAV, Vikas BHANDARI, Sameer Ramanlal MODI, . HEMLATA
  • Publication number: 20200246263
    Abstract: The present invention relates to a stable liquid pharmaceutical composition of pemetrexed for parenteral administration. The invention provides composition comprising pemetrexed diacid, an organic amine and cyclodextrin. The composition may further comprise an inert gas. The composition can be ready to use infusion solution of pemetrexed diacid or liquid concentrate formulation to be diluted before administration to the patient. The present invention further relates to a process for manufacturing the compositions as well as use of the compositions of the invention for the treatment of malignant pleural mesothelioma and non-small cell lung cancer.
    Type: Application
    Filed: August 28, 2018
    Publication date: August 6, 2020
    Applicant: FRESENIUS KABI ONCOLOGY LIMITED
    Inventors: Dhiraj KHATTAR, Rajesh KHANNA, Abhilasha YADAV, Vikas BHANDARI, Sameer Ramanlal MODI, Hemlata
  • Publication number: 20110301189
    Abstract: A stable pharmaceutical compositions of Rapamycin Esters, in particular Rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid that is free of antioxidants and a process of preparing the same.
    Type: Application
    Filed: June 2, 2011
    Publication date: December 8, 2011
    Applicant: FRESENIUS KABI ONCOLOGY LTD.
    Inventors: Dhiraj Khattar, Rajesh Khanna, Poonam Singla, Abhilasha Yadav, Vinay Gupta, Rajesh Kini, Sushil Kumar Dubey